Gilteritinib hemifumarate
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 1254053-84-3 | Cat. No. | BCP40569 |
| Name | Gilteritinib hemifumarate | ||
| Synonyms | Gilteritinib fumarate;ASP-2215 hemifumarate;ASP2215 hemifumarate;ASP 2215 hemifumarate; | ||
| SMILES | CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.C(=CC(=O)O)C(=O)O | ||
| Chemical Name | |||
| Formula | C62H92N16O10 | M. Wt | 1221.52 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Gilteritinib, also known as ASP2215, is a potent FLT3/AXL inhibitor, which showed potent antileukemic activity against AML with either or both FLT3-ITD and FLT3-D835 mutations. In invitro, among the 78 tyrosine kinases tested, ASP2215 inhibited FLT3, LTK, ALK, and AXL kinases by over 50% at 1 nM with an IC50 value of 0.29 nM for FLT3, approximately 800-fold more potent than for c-KIT, the inhibition of which is linked to a potential risk of myelosuppression. ASP2215 inhibited the growth of MV4-11 cells, which harbor FLT3-ITD, with an IC50 value of 0.92 nM, accompanied with inhibition of pFLT3, pAKT, pSTAT5, pERK, and pS6. ASP2215 decreased tumor burden in bone marrow and prolonged the survival of mice intravenously transplanted with MV4-11 cells. ASP2215 may have potential use in treating AML. | ||
Recommend Products
More >
-
Batiraxcept
Cat. No.：BCP49357
No.：2268717-61-7
Product Details -
Ningetinib
Cat. No.：BCP46143
No.：1394820-69-9
Product Details -
-
-
-
-
-
S49076 HCl
Cat. No.：BCP29576
No.：1265966-31-1
Product Details -
Sitravatinib
Cat. No.：BCP29099
No.：1123837-84-2
Product Details -
BMS 777607
Cat. No.：BCP13190
No.：1196681-44-3
Product Details -
CEP-40783
Cat. No.：BCP25839
No.：1437321-24-8
Product Details -
Glesatinib hydrochloride
Cat. No.：BCP18872
No.：1123838-51-6
Product Details -
-
-
-
-
-
-
-
Tags:Gilteritinib hemifumarate supplier,Gilteritinib hemifumarate purchase,Gilteritinib hemifumarate manufacturer,Gilteritinib hemifumarate distributor,Gilteritinib hemifumarate cost,Gilteritinib hemifumarate buy,Gilteritinib hemifumarate for sale